Government stimulus packages are pushing companies to reconsider reshoring to the US for domestic manufacturing. Tariffs under the Trump administration aim to boost US production, but reshoring is complex and costly. Companies face challenges like building new facilities and navigating labour laws. Partial reshoring may be a more feasible option for many.

Nearshoring offers a balanced approach, moving production closer to sourcing or consumers. Companies can avoid high tariffs and benefit from lower labour costs and shipping times. However, decisions on nearshoring to Mexico and Canada may be delayed pending USMCA renegotiation. Industry and market location dictate the best supply chain model.

Certain industries, like textiles and consumer electronics, won’t reshore production due to cost constraints. Advanced sectors like semiconductors and pharmaceuticals are more likely to reshore, driven by IP protection, automation, and government incentives. Major companies like Roche, Novartis, and Apple are investing billions in reshoring to the US.

Apple’s complex supply chain faces pressure to reshore due to tariff threats. While pledging billions to support suppliers in reshoring, fully reshoring all production is financially unfeasible. Most companies will opt for nearshoring or reshoring select parts of their supply chain to manage costs and remain competitive.

Read more at Yahoo Finance: US companies considering reshoring must find the right balance